FeesSafety
Pluang+

Quanex Building Products shares rise 12.7% with strong profit growth despite housing market challenges

Analyst Insights
18 Nov 2026, 08:23 WIB
Seeking Alpha
View Source
Bullish
Quanex Building Products shares rise 12.7% with strong profit growth despite housing market challenges

Quanex Building Products has been a strong performer, with shares up 12.7% since August. The company showed resilient revenue and profit growth, with adjusted net profits increasing from $31.6 million to $36 million despite challenges in the housing market. Its valuation remains attractive compared to peers, supported by ongoing strength in the repair and remodeling sector. While housing market risks persist, recent strong results suggest continued upside potential for investors.

Quanex Building Products is the subject of this story, and here is Pluang's market snapshot as of Nov 18, 2026 13:41 WIB: Among 134 Consumer Cyclical-sector US stocks priced on Pluang, 49 rose and 84 fell today. Notable movers include Newegg Commerce Inc (NEGG) at USD 7.88 with a 1-day change of -8.58% and 100% sell order activity, Capri Holdings Ltd (CPRI) at USD 18.95 down 7.79%, and ThredUp Inc (TDUP) at USD 1.50 down 6.25%.

More News

ZTO Express beats Q3 earnings and revenue estimates with 21% revenue growth and rising parcel volume.

ZTO Express beats Q3 earnings and revenue estimates with 21% revenue growth and rising parcel volume.

ZTO Express (Cayman) Inc. reported Q3 2026 earnings per share of $0.48, surpassing estimates of $0.4665, and revenue of $2.14 billion, exceeding the $2.08 billion forecast. The company saw a 21% year-over-year revenue increase to CNY 14.4 billion and...

Company Fundamentals
Bullish
2 hours ago
Temporal launches Supermassive, a fully onchain perpetual futures exchange on Solana, debuting in January 2027.

Temporal launches Supermassive, a fully onchain perpetual futures exchange on Solana, debuting in January 2027.

Temporal announced Supermassive, a new perpetual futures exchange built entirely on Solana's blockchain, set to launch on mainnet in January 2027. This platform separates trading and clearing, allowing multiple venues and market makers to compete for...

Market News
Bullish
4 hours ago
Curve Finance lost $38,200 in DAO fees due to a contract flaw exploited in 138 fake trades on Nov 10.

Curve Finance lost $38,200 in DAO fees due to a contract flaw exploited in 138 fake trades on Nov 10.

On November 10, an attacker exploited a signature verification flaw in Curve Finance's CowSwapBurner contract, stealing about $38,200 in DAO fee revenue through 138 unauthorized trades. The vulnerability allowed fraudulent orders to bypass checks and...

Market News
Bearish
5 hours ago
Pfizer beats Q3 revenue estimates, raises 2026 guidance, and shows strong margin growth.

Pfizer beats Q3 revenue estimates, raises 2026 guidance, and shows strong margin growth.

Pfizer reported Q3 revenue of $16.58 billion, exceeding estimates by $700 million, driven by a 32% growth in launched and acquired products and an improved gross margin of about 77%. The company raised its full-year 2026 revenue guidance to $62 billi...

Analyst Insights
Bullish
5 hours ago
Zealand Pharma starts Phase 2 trial of petrelintide and enicepatide combo for obesity treatment

Zealand Pharma starts Phase 2 trial of petrelintide and enicepatide combo for obesity treatment

Zealand Pharma has initiated the Phase 2 ZYNERGY trial to test the safety and effectiveness of petrelintide combined with enicepatide in people with obesity or overweight with related health issues. The trial will evaluate three dosing regimens over ...

Company Fundamentals
Bullish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App